Dyadic International Inc (DYAI) stock
DYAINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.32+0.00 (+1.30%)
Close on Nov 18, 2026Market cap $11.66MP/E –Yield –
Dyadic International price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Dyadic International's price to sales ratio was 3.7× on Nov 11, 2026, against 10.3× a year earlier. Over the last 5 years it ranged from 0.2× to 44.3×, with a median of 14.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.7× | −6.5 |
| 2025 | Dec 31, 2025 | 10.2× | −5.2 |
| 2024 | Dec 31, 2024 | 15.4× | −0.3 |
| 2023 | Dec 29, 2023 | 15.7× | +1.7 |
| 2022 | Dec 30, 2022 | 14.0× | +13.7 |
| 2021 | Dec 31, 2021 | 0.3× | −87.3 |
| 2020 | Dec 31, 2020 | 87.5× | +14.7 |
| 2019 | Dec 31, 2019 | 72.9× | +2.3 |
| 2018 | Dec 31, 2018 | 70.6× | – |
See a number that looks wrong?